Skip to main content
Erschienen in: Pediatric Surgery International 1/2023

01.12.2023 | Original Article

Effectiveness of indocyanine green fluorescence imaging in resection of hepatoblastoma

verfasst von: Qiyang Shen, Xingyu Liu, Sirui Pan, Tao Li, Jianfeng Zhou

Erschienen in: Pediatric Surgery International | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

The present research aimed to analyze the application of indocyanine green (ICG) fluorescence contrast technique in the resection of hepatoblastoma (HB) in children, and to discuss the use of ICG in the surgery of HB and the value of guidance.

Methods

We retrospectively analyzed the data of 23 children with HB resected using ICG fluorescence contrast technique at the Children’s Hospital of Nanjing Medical University from June 2020 to September 2022, including 16 boys and 7 girls, aged 5 days to 80 months. The patients were administered with an ICG injection of 0.1 mg/kg around 24–48 h before surgery. The surgical margin was detected by real-time fluorescence imaging and confirmed by postoperative pathology.

Results

All primary lesions showed bright fluorescence in 23 HB cases. 22 had clear borders with normal liver tissue, while one neonatal case showed no difference between tumor and background. 13 anatomic resection and 10 non-anatomic resection were performed with ICG fluorescence navigation. The surface of the residual liver was scattered with multiple tumor fluorescence, which was then locally enucleated according to the fluorescence. 22 isolated specimens were dissected and fluorescently visualized. Pathology identified deformed, vacuolated and densely arranged hepatocytes resembling pseudo-envelope changes without tumor residual, due to the compression of the tissue at the site of circumferential imaging.

Conclusion

The ring ICG fluorescence imaging of HB indicates the tumor resection boundary effectively, especially in multiple lesions cases.
Literatur
1.
Zurück zum Zitat O’Neill AF et al (2017) Characterization of pulmonary metastases in children with hepatoblastoma treated on children’s oncology group protocol AHEP0731 (the treatment of children with all stages of hepatoblastoma): a report from the children’s oncology group. J Clin Oncol 35(30):3465–3473CrossRefPubMedPubMedCentral O’Neill AF et al (2017) Characterization of pulmonary metastases in children with hepatoblastoma treated on children’s oncology group protocol AHEP0731 (the treatment of children with all stages of hepatoblastoma): a report from the children’s oncology group. J Clin Oncol 35(30):3465–3473CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Meyers RL et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children’s hepatic tumors international collaboration. Lancet Oncol 18(1):122–131CrossRefPubMed Meyers RL et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children’s hepatic tumors international collaboration. Lancet Oncol 18(1):122–131CrossRefPubMed
4.
Zurück zum Zitat Kalish JM et al (2017) Surveillance recommendations for children with overgrowth syndromes and predisposition to wilms tumors and hepatoblastoma. Clin Cancer Res 23(13):e115–e122CrossRefPubMedPubMedCentral Kalish JM et al (2017) Surveillance recommendations for children with overgrowth syndromes and predisposition to wilms tumors and hepatoblastoma. Clin Cancer Res 23(13):e115–e122CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Sivaprakasam P et al (2011) Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin. J Pediatr Hematol Oncol 33(6):e226–e230CrossRefPubMed Sivaprakasam P et al (2011) Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin. J Pediatr Hematol Oncol 33(6):e226–e230CrossRefPubMed
6.
Zurück zum Zitat Hooks KB et al (2018) New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology 68(1):89–102CrossRefPubMed Hooks KB et al (2018) New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology 68(1):89–102CrossRefPubMed
7.
Zurück zum Zitat Choy G, Choyke P, Libutti SK (2003) Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2(4):303–312CrossRefPubMed Choy G, Choyke P, Libutti SK (2003) Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2(4):303–312CrossRefPubMed
8.
Zurück zum Zitat Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7(5):626–634CrossRefPubMed Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7(5):626–634CrossRefPubMed
9.
Zurück zum Zitat Landsman ML et al (1976) Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol 40(4):575–583CrossRefPubMed Landsman ML et al (1976) Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol 40(4):575–583CrossRefPubMed
10.
Zurück zum Zitat Yamada Y et al (2019) Fluorescence-guided surgery for hepatoblastoma with indocyanine green. Cancers (Basel) 11(8):1215CrossRefPubMed Yamada Y et al (2019) Fluorescence-guided surgery for hepatoblastoma with indocyanine green. Cancers (Basel) 11(8):1215CrossRefPubMed
11.
Zurück zum Zitat Ishizawa T et al (2009) Intraoperative fluorescent cholangiography using indocyanine green: a biliary road map for safe surgery. J Am Coll Surg 208(1):e1-4CrossRefPubMed Ishizawa T et al (2009) Intraoperative fluorescent cholangiography using indocyanine green: a biliary road map for safe surgery. J Am Coll Surg 208(1):e1-4CrossRefPubMed
12.
Zurück zum Zitat Fox IJ et al (1957) A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Proc Staff Meet Mayo Clin 32(18):478–484PubMed Fox IJ et al (1957) A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Proc Staff Meet Mayo Clin 32(18):478–484PubMed
13.
Zurück zum Zitat Speich R et al (1988) Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med 109(4):345–346CrossRefPubMed Speich R et al (1988) Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med 109(4):345–346CrossRefPubMed
14.
Zurück zum Zitat Ishizawa T et al (2014) Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol 21(2):440–448CrossRefPubMed Ishizawa T et al (2014) Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol 21(2):440–448CrossRefPubMed
15.
Zurück zum Zitat Cheung TT et al (2018) Pure laparoscopic hepatectomy with augmented reality-assisted indocyanine green fluorescence versus open hepatectomy for hepatocellular carcinoma with liver cirrhosis: a propensity analysis at a single center. Asian J Endosc Surg 11(2):104–111CrossRefPubMed Cheung TT et al (2018) Pure laparoscopic hepatectomy with augmented reality-assisted indocyanine green fluorescence versus open hepatectomy for hepatocellular carcinoma with liver cirrhosis: a propensity analysis at a single center. Asian J Endosc Surg 11(2):104–111CrossRefPubMed
16.
Zurück zum Zitat Wang Z et al (2018) Method for real-time tissue quantification of indocyanine green revealing optimal conditions for near infrared fluorescence guided surgery. Anal Chem 90(13):7922–7929CrossRefPubMed Wang Z et al (2018) Method for real-time tissue quantification of indocyanine green revealing optimal conditions for near infrared fluorescence guided surgery. Anal Chem 90(13):7922–7929CrossRefPubMed
17.
Zurück zum Zitat de Graaf W et al (2011) Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol 54(4):738–745CrossRefPubMed de Graaf W et al (2011) Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol 54(4):738–745CrossRefPubMed
18.
Zurück zum Zitat Lake CM et al (2021) Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma. Cancer Med 10(13):4322–4343CrossRefPubMedPubMedCentral Lake CM et al (2021) Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma. Cancer Med 10(13):4322–4343CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Narasaki H et al (2017) Intraoperative real-time assessment of liver function with near-infrared fluorescence imaging. Eur Surg Res 58(5–6):235–245CrossRefPubMed Narasaki H et al (2017) Intraoperative real-time assessment of liver function with near-infrared fluorescence imaging. Eur Surg Res 58(5–6):235–245CrossRefPubMed
21.
Zurück zum Zitat Nakaseko Y, Ishizawa T, Saiura A (2018) Fluorescence-guided surgery for liver tumors. J Surg Oncol 118(2):324–331CrossRefPubMed Nakaseko Y, Ishizawa T, Saiura A (2018) Fluorescence-guided surgery for liver tumors. J Surg Oncol 118(2):324–331CrossRefPubMed
22.
Zurück zum Zitat Yamamichi T et al (2015) Clinical application of indocyanine green (ICG) fluorescent imaging of hepatoblastoma. J Pediatr Surg 50(5):833–836CrossRefPubMed Yamamichi T et al (2015) Clinical application of indocyanine green (ICG) fluorescent imaging of hepatoblastoma. J Pediatr Surg 50(5):833–836CrossRefPubMed
23.
Zurück zum Zitat Cho YJ et al (2021) The advantages of indocyanine green fluorescence imaging in detecting and treating pediatric hepatoblastoma: a preliminary experience. Front Pediatr 9:635394CrossRefPubMedPubMedCentral Cho YJ et al (2021) The advantages of indocyanine green fluorescence imaging in detecting and treating pediatric hepatoblastoma: a preliminary experience. Front Pediatr 9:635394CrossRefPubMedPubMedCentral
Metadaten
Titel
Effectiveness of indocyanine green fluorescence imaging in resection of hepatoblastoma
verfasst von
Qiyang Shen
Xingyu Liu
Sirui Pan
Tao Li
Jianfeng Zhou
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 1/2023
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-023-05465-3

Weitere Artikel der Ausgabe 1/2023

Pediatric Surgery International 1/2023 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.